Distribution leverage Leverage Hanger Orthopedic Group's expansive distribution and clinical partnerships to accelerate WalkAide adoption across hospitals, clinics, and outpatient rehab centers in the United States, enabling co-sell opportunities through existing channels.

Analytics edge The March 2022 expansion of analytic capabilities within ZBEdge signals a data-driven value proposition; position WalkAide and related neuromuscular tech as outcomes-focused devices with measurable ROI that can be integrated with existing EMR and analytics workflows.

Academic pilots Innovative Neurotronics’ model of surfacing emerging neuromuscular technologies via major research centers and universities creates clear paths for pilots, proof-of-concept studies, and early-adopter contracts with academic and research partners.

Niche scalability With a small to mid-size team and revenue scale, target cost-conscious rehab facilities and mid-tier clinics that need scalable, affordable neuromuscular solutions that can be rapidly deployed and supported.

Bundled offerings Propose bundled packages that combine WalkAide devices with ZBEdge analytics and AI-driven insights, leveraging Hanger’s channels to differentiate from larger competitors and drive faster adoption.